Creating a laboratory to prevent cancer through immunotherapy.
DCP- Cancer Immunoprevention Laboratory Support
This study is setting up a new lab to find better ways to use the immune system to help prevent cancer, and it aims to create helpful strategies that could benefit patients in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-11219782 on NIH RePORTER |
What this research studies
This research aims to establish a new Cancer Immunoprevention Laboratory dedicated to advancing methods that help prevent cancer through immunotherapy. The laboratory will serve as a reference facility, confirming results from various contractors and ensuring standardized methods are used in the development of immunoprevention strategies. By focusing on preclinical development, the laboratory will work on innovative concepts that could lead to effective cancer prevention techniques. Patients may benefit from the advancements made in understanding how to harness the immune system to prevent cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for developing cancer or those interested in preventive measures against malignancies.
Not a fit: Patients with existing cancer diagnoses may not receive direct benefits from this research focused on prevention.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing cancer, potentially reducing the incidence of malignant tumors.
How similar studies have performed: Other research in cancer immunoprevention has shown promise, indicating that this approach could lead to significant advancements in cancer prevention strategies.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Briscoe, Lynn — Leidos Biomedical Research, INC.
- Study coordinator: Briscoe, Lynn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.